<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comentários em: Carboximaltose férrica em doentes com DRC: um fármaco com “impacto positivo” na prática clínica	</title>
	<atom:link href="https://mediconews.pt/carboximaltose-ferrica-em-doentes-com-drc-um-farmaco-com-impacto-positivo-na-pratica-clinica/feed/" rel="self" type="application/rss+xml" />
	<link>https://mediconews.pt/carboximaltose-ferrica-em-doentes-com-drc-um-farmaco-com-impacto-positivo-na-pratica-clinica/</link>
	<description>Dar voz à experiência clínica dos profissionais de saúde no nosso país, através de depoimentos dos key opinion leaders das respetivas especialidades.</description>
	<lastBuildDate>Tue, 30 Aug 2022 21:27:33 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.1</generator>
</channel>
</rss>
